Aijun Chen

Selection and characterization of DNA aptamers for use in detection of avian influenza virus H5N1

A split, conditionally active mimetic of IL-2 reduces the toxicity of systemic cytokine therapy

Antibody-cytokine fusion proteins: Biopharmaceuticals with immunomodulatory properties for cancer therapy

Leishmaniasis

Gene Therapy-Mediated Reprogramming Tumor Infiltrating T Cells Using IL-2 and Inhibiting NF-κB Signaling Improves the Efficacy of Immunotherapy in a Brain Cancer Model

Selection of DNA aptamers that bind to influenza A viruses with high affinity and broad subtype specificity

The cytokine storm of severe influenza and development of immunomodulatory therapy

Aptamers as targeted therapeutics: current potential and challenges

Vector-mediated gene transfer engenders long-lived neutralizing activity and protection against SIV infection in monkeys

Adeno-associated virus vector as a platform for gene therapy delivery

A fluorescent aptasensor for H5N1 influenza virus detection based-on the core–shell nanoparticles metal-enhanced fluorescence (MEF)

Isolation of Single-Stranded DNA Aptamers That Distinguish Influenza Virus Hemagglutinin Subtype H1 from H5

Characteristics of human infection with avian influenza viruses and development of new antiviral agents

Assessment of quality of life in patients with post kalaazar dermal leishmaniasis

Rapid Diagnostic Assay for Intact Influenza Virus Using a High Affinity Hemagglutinin Binding Protein

Aptamer-Based Therapeutics: New Approaches to Combat Human Viral Diseases

Aptamer Nanomedicine for Cancer Therapeutics: Barriers and Potential for Translation

Nanotechnology for Multimodal Synergistic Cancer Therapy

Health-Related Quality of Life in Patients with Primary Cutaneous Amyloidosis

Construction and delivery of gene therapy vector containing soluble TNFα receptor-IgGFc fusion gene for the treatment of allergic rhinitis

Inhibitory effect of small interfering RNA specific for a novel candidate target in PB1 gene of influenza A virus

Enhanced immune response induced by a potential influenza A vaccine based on branched M2e polypeptides linked to tuftsin

Potent inhibition of human influenza H5N1 virus by oligonucleotides derived by SELEX